|
DLC1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.685000E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.401140E-03 |
| Normal-vs-Stage2 |
1.874250E-01 |
| Normal-vs-Stage3 |
2.067800E-01 |
| Normal-vs-Stage4 |
6.675900E-03 |
| Stage1-vs-Stage2 |
6.774400E-04 |
| Stage1-vs-Stage3 |
1.88697999999876E-05 |
| Stage1-vs-Stage4 |
1.36429999963994E-07 |
| Stage2-vs-Stage3 |
6.300600E-01 |
| Stage2-vs-Stage4 |
3.958400E-01 |
| Stage3-vs-Stage4 |
9.261800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.675800E-01 |
| Normal-vs-AfricanAmerican |
6.933200E-01 |
| Normal-vs-Asian |
6.188400E-01 |
| Caucasian-vs-AfricanAmerican |
4.182400E-01 |
| Caucasian-vs-Asian |
5.613600E-01 |
| AfricanAmerican-vs-Asian |
4.773200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.151800E-01 |
| Normal-vs-Female |
3.788200E-02 |
| Male-vs-Female |
1.112270E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.739200E-01 |
| Normal-vs-Age(41-60Yrs) |
8.748100E-02 |
| Normal-vs-Age(61-80Yrs) |
7.151400E-01 |
| Normal-vs-Age(81-100Yrs) |
4.344000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.191800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.488800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.674400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.553600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.776980E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.299000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.502100E-02 |
| Normal-vs-Grade 2 |
6.634000E-04 |
| Normal-vs-Grade 3 |
5.302300E-02 |
| Normal-vs-Grade 4 |
4.464100E-02 |
| Grade 1-vs-Grade 2 |
2.736200E-01 |
| Grade 1-vs-Grade 3 |
2.158500E-02 |
| Grade 1-vs-Grade 4 |
1.441070E-03 |
| Grade 2-vs-Grade 3 |
5.04110000409952E-08 |
| Grade 2-vs-Grade 4 |
4.46170000000246E-05 |
| Grade 3-vs-Grade 4 |
4.244600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.805100E-04 |
| Normal-vs-ccB subtype |
2.929800E-01 |
| ccA subtype-vs-ccB subtype |
1.76887999999709E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.152600E-01 |
| Normal-vs-N1 |
6.860200E-02 |
| N0-vs-N1 |
1.016560E-01 |
|
|
